Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

- Kneebone, Andrew, Fraser-Browne, Carol, Duchesne, Gillian M., Fisher, Richard, Frydenberg, Mark, Herschtal, Alan, Williams, Scott G., Brown, Chris, Delprado, Waeick, Haworth, Annette, Joseph, David J., Martin, Jarad M., Matthews, John H. L., Millar, Jeremy L., Sidhom, Milllar, Spry, Nigel, Tang, Colin I., Turner, Sandra, Wiltshire, Kirsty L., Woo, Henry H., Davis, Ian D., Lim, Tee S., Pearse, Maria

Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants

- Haworth, Annette, Ebert, Martin A., St. Clair, Shaun, Carey, Brendan M., Flynn, Anthony, Bottomley, David M., Duchesne, Gillian M., Joseph, David, Ash, Daniel

Researching depression in prostate cancer patients: factors, timing, and measures

- Sharpley, Christopher F., Bitsika, Vicki, Christie, David R. H., Denham, James W., Duchesne, Gillian M., Couper, Jeremy W.

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

- Duchesne, Gillian M., Woo, Henry H., Millar, Jeremy, Milne, Roger, Smith, Rosemary G., Spry, Nigel, Stockler, Martin, Syme, Rodney A., Tai, Keen Hun, Turner, Sandra, Bassett, Julie K., Bowe, Steven J., D'Este, Catherine, Frydenberg, Mark, King, Madeleine, Ledwich, Leo, Loblaw, Andrew, Malone, Shawn